Abstract
As hypoxia is a major driver for the pathophysiology of COVID-19, it is crucial to characterize the hypoxic response at the cellular and molecular levels. In order to augment drug repurposing with the identification of appropriate molecular targets, investigations on therapeutics preventing hypoxic cell damage is required. In this work, we propose a hypoxia model based on alveolar lung epithelial cells line using chemical inducer, CoCl 2 that can be used for testing calcium channel blockers (CCBs). Since recent studies suggested that CCBs may reduce the infectivity of SARS-Cov-2, we specifically select FDA approved calcium channel blocker, nifedipine for the study. First, we examined hypoxia-induced cell morphology and found a significant increase in cytosolic calcium levels, mitochondrial calcium overload as well as ROS production in hypoxic A549 cells. Secondly, we demonstrate the protective behaviour of nifedipine for cells that are already subjected to hypoxia through measurement of cell viability as well as 4D imaging of cellular morphology and nuclear condensation. Thirdly, we show that the protective effect of nifedipine is achieved through the reduction of cytosolic calcium, mitochondrial calcium, and ROS generation. Overall, we outline a framework for quantitative analysis of mitochondrial calcium and ROS using 3D imaging in laser scanning confocal microscopy and the open-source image analysis platform ImageJ. The proposed pipeline was used to visualize mitochondrial calcium and ROS level in individual cells that provide an understanding of molecular targets. Our findings suggest that the therapeutic value of nifedipine may potentially be evaluated in the context of COVID-19 therapeutic trials.
Keywords: Calcium channel blocker; Hypoxia; Mitochondrial calcium; Nifedipine; Reactive oxygen species (ROS); SARS-Cov-2.
【저자키워드】 SARS-CoV-2, hypoxia, reactive oxygen species (ROS), Calcium channel blocker, Mitochondrial calcium, Nifedipine, 【초록키워드】 COVID-19, oxygen, FDA, pathophysiology, viability, therapeutic, ROS, morphology, targets, molecular, platform, trials, protective effect, Protective, cellular, CCB, Analysis, mitochondrial, confocal microscopy, reduction, Quantitative analysis, calcium channel, significant increase, A549 cells, CCBs, blocker, ROS production, inducer, nuclear, alveolar, cell damage, Cell, hypoxic, was used, examined, evaluated, required, approved, can be used, suggested, reduce, cellular and molecular, cytosolic, lung epithelial cell, ImageJ, individual cell, 【제목키워드】 FDA, cell death, mitochondrial, modulation, L-type, hypoxic, approved, reduce, A549 cell,